[Clinical experimentation with injectable Parapenzolate in urology].
D001561:Benzilates / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007410:Intestinal Diseases / Q000188:drug therapy; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy*; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014545:Urinary Calculi / Q000188:drug therapy*; D014570:Urologic Diseases / Q000188:drug therapy
D001561:Benzilates; D010276:Parasympatholytics; D010880:Piperidines; D000644:Quaternary Ammonium Compounds
Expérimentation clinique du Parapenzolate injectable en urologie.